These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 338851)

  • 21. [Multi-centric study for the evaluation of the antihypertensive efficacy of hydrochlorothiazide and spironolactone association: comparison between 2 dosages schemes].
    Fariello R; Porcellati C; Innocenti PF; Corea L; Roncati G
    Clin Ter; 1983 Jun; 105(6):477-85. PubMed ID: 6617110
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension.
    Charansonney OL; Lièvre M; Laville M; Lion L; Derobert E; Visèle N; Decourt S; de Rusunan MP; Luciani J; Vasmant D; Boissel JP; Grünfeld JP
    Therapie; 1997; 52(3):169-77. PubMed ID: 9366100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of low doses of hydrochlorothiazide plus amiloride and hydrochlorothiazide alone in hypertension in elderly patients.
    Salmela PI; Juustila H; Kinnunen O; Koistinen P
    Ann Clin Res; 1986; 18(2):88-92. PubMed ID: 3521443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
    Frishman WH; Goldberger J; Sherman D
    J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension. ATHES Study Group.
    Genthon R
    Int J Clin Pharmacol Res; 1994; 14(1):1-9. PubMed ID: 7927956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 32. [Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1977 Sep; 107(35):1228-32. PubMed ID: 335498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of spironolactone and hydrochlorothiazide on blood pressure levels and blood potassium. Controlled studies on hypertensive patients].
    Ambrosioni E; Costa FV; Magnani B
    G Clin Med; 1974 Nov; 55(11):782-97. PubMed ID: 4469883
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind assessment of tienilic acid in essential hypertension.
    Freis ED
    Postgrad Med J; 1979; 55 Suppl 3():92-7. PubMed ID: 388402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind therapeutic trial of spironolactone in arterial hypertension].
    Chávez-Domínguez R; Sánchez-Torres G; Serrano P
    Arch Inst Cardiol Mex; 1975; 45(4):487-94. PubMed ID: 1101838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
    Jørgensen F; Bredesgaard P; Johansen P
    Pharmatherapeutica; 1986; 4(10):655-64. PubMed ID: 3602017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
    Morabito S; Fabiano M; Puliti M; Palumbo R; Marinelli R; Simonetti BM; Pierucci A
    Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of low-dose spironolactone on resistant hypertension.
    Engbaek M; Hjerrild M; Hallas J; Jacobsen IA
    J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pindolol on potassium homeostasis in patients with essential hypertension.
    Garrett BN; Ram CV; Kaplan NM
    Clin Ther; 1984; 6(4):524-35. PubMed ID: 6547878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.